CSLLY Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 май 2024 @ 22:57):

Stats
Объем за сегодня	50 646.00
Средний объем	34 347.00
Рыночная капитализация	86.15B
Last Dividend	$0.645 ( 2023-09-08 )
Next Dividend	$0 ( N/A )
P/E	35.09
ATR14	$0.603 (0.68%)

Объем Корреляция

Длинно: 0.08 (neutral)

Кратко: 0.81 (strong)

Signal:(47.236) Same movement expected

CSL Limited Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

CSL Limited Корреляция - Валюта/Сырье

0.44
( neutral )

0.47
( neutral )

0.43
( neutral )

0.35
( neutral )

-0.54
( weak negative )

-0.19
( neutral )

CSL Limited Финансовые показатели

Annual	2023
Выручка:	$13.17B
Валовая прибыль:	$6.71B (50.92 %)
EPS:	$2.27

FY	2023
Выручка:	$13.17B
Валовая прибыль:	$6.71B (50.92 %)
EPS:	$2.27

FY	2022
Выручка:	$10.49B
Валовая прибыль:	$5.66B (53.97 %)
EPS:	$2.40

FY	2021
Выручка:	$10.27B
Валовая прибыль:	$5.80B (56.49 %)
EPS:	$2.62

Financial Reports:

No articles found.

CSL Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.590 (N/A)	$0 (N/A)	$0.535 (N/A)	$0 (N/A)	$0.645 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

CSL Limited Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.59 - Stable (31.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.158	2010-03-10
Last Dividend	$0.645	2023-09-08
Next Dividend	$0	N/A
Payout Date	2023-09-09
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	$10.42	--
Avg. Dividend % Per Year	0.00%	--
Score	4.16	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.59
Div. Directional Score	9.59	--

Next Divdend (Est)
(2024-07-01)

$0.671 Estimate 7.55 %

Dividend Stability

0.30 Poor

Dividend Score

4.16

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
YITYY	Ex Dividend Junior	2023-10-02	Annually	0.00%
MHGVY	Ex Dividend Knight	2023-09-01	Quarterly	0.00%
CNAF	Ex Dividend Knight	2023-08-24	Quarterly	0.00%
SSEZY	Ex Dividend Knight	2023-07-27	Semi-Annually	0.00%
HFBK	Ex Dividend Knight	2023-08-24	Quarterly	0.00%
AMNF	Ex Dividend Knight	2023-07-06	Quarterly	0.00%
NXGPY	Ex Dividend Knight	2023-07-06	Semi-Annually	0.00%
CWBK	Ex Dividend Junior	2023-09-14	Quarterly	0.00%
TMSNY	Ex Dividend Junior	2023-05-05	Annually	0.00%
IKTSY	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.177	1.500	6.45	9.68	[0 - 0.5]
returnOnAssetsTTM	0.118	1.200	6.06	7.27	[0 - 0.3]
returnOnEquityTTM	0.212	1.500	8.76	10.00	[0.1 - 1]
payoutRatioTTM	0.258	-1.000	7.42	-7.42	[0 - 1]
currentRatioTTM	2.15	0.800	4.25	3.40	[1 - 3]
quickRatioTTM	0.971	0.800	9.00	7.20	[0.8 - 2.5]
cashRatioTTM	0.216	1.500	9.91	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.30	-7.95	[0 - 0.6]
interestCoverageTTM	9.55	1.000	7.58	7.58	[3 - 30]
operatingCashFlowPerShareTTM	4.17	2.00	8.61	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.00	2.00	9.00	10.00	[0 - 20]
debtEquityRatioTTM	0.612	-1.500	7.55	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.498	1.000	5.04	5.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.250	1.000	7.01	7.01	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.383	1.000	8.99	8.99	[0.2 - 2]
assetTurnoverTTM	0.666	0.800	8.89	7.11	[0.5 - 2]
Total Score				12.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	19.53	1.000	8.13	0	[1 - 100]
returnOnEquityTTM	0.212	2.50	9.20	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.00	2.00	9.33	10.00	[0 - 30]
dividendYielPercentageTTM	1.391	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.17	2.00	8.61	10.00	[0 - 30]
payoutRatioTTM	0.258	1.500	7.42	-7.42	[0 - 1]
pegRatioTTM	0.432	1.500	-0.455	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.162	1.000	8.45	0	[0.1 - 0.5]
Total Score				6.59

CSL Limited

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.